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Abstract Because mouse embryonic stem cells (mESCs)
do not contribute to the formation of extraembryonic
placenta when they are injected into blastocysts, it is
believed that mESCs do not differentiate into trophoblast
whereas human embryonic stem cells (hESCs) can express
trophoblast markers when exposed to bone morphogenetic
protein 4 (BMP4) in vitro. To test whether mESCs have the
potential to differentiate into trophoblast, we assessed the
effect of BMP4 on mESCs in a defined monolayer culture
condition. The expression of trophoblast-specific transcrip-
tion factors such as Cdx2, Dlx3, Esx1, Gata3, Hand1,
Mash2,a n dPlx1 was specifically upregulated in the
BMP4-treated differentiated cells, and these cells expressed
trophoblast markers. These results suggest that BMP4
treatment in defined culture conditions enabled mESCs to
differentiate into trophoblast. This differentiation was
inhibited by serum or leukemia inhibitory factor, which
are generally used for mESC culture. In addition, we
studied the mechanism underlying BMP4-directed mESC
differentiation into trophoblast. Our results showed that
BMP4 activates the Smad pathway in mESCs inducing
Cdx2 expression, which plays a crucial role in trophoblast
differentiation, through the binding of Smad protein to the
Cdx2 genomic enhancer sequence. Our findings imply that
there is a common molecular mechanism underlying hESC
and mESC differentiation into trophoblast.
Keywords BMP4.Smad.Cdx2.Trophoblast.Mouse
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Introduction
Mouse embryonic stem cells (mESCs) are pluripotent cells
derived from the inner cell mass (ICM) of the blastocyst,
which differentiate into all the three germ layers in vitro
and in vivo (Evans and Kaufman 1981; Martin 1981).
However, mESCs are thought to be incapable of differen-
tiating into trophoblast because they do not contribute to
placenta in chimeric mouse (Beddington and Robertson
1989). To obtain placental trophoblast from mESCs,
genetic manipulations of transcription factors or signaling
molecules have been reported, such as the decreased
expression of Oct3/4 (Niwa et al. 2000)o rSox2 (Masui et
al. 2007) or overexpression of Cdx2 (Niwa et al. 2005;
Tolkunova et al. 2006), Eomes (Niwa et al. 2005), Ras (Lu
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fundamental molecular mechanisms regulating the differ-
entiation of ESCs into trophoblast have not yet been
elucidated. Human embryonic stem cells (hESCs) have
been reported to express trophoblast markers after treatment
with bone morphogenetic protein 4 (BMP4) in vitro (Xu et
al. 2002). By contrast, the effect of BMP4 on mESCs is still
unclear (Kunath et al. 2007). BMP4 is thought to be
involved in activin- or Wnt-induced mesoderm induction or
mesodermal tissue specification from ESCs (Johansson and
Wiles 1995; Wiles and Johansson 1999; Nostro et al. 2008;
Sumi et al. 2008). Coordinating with leukemia inhibitory
factor (LIF), BMP4 also supports the mESC self-renewal in
defined culture conditions (Ying et al. 2003; Qi et al. 2004).
Recently, Smith and his colleagues have suggested that
to elucidate physiologically relevant molecular signals in
mESCs, culture conditions with fewer extrinsic stimulators
are beneficial (Ying et al. 2008). We previously developed a
chemically defined simple serum-free culture condition for
mESCs (Furue et al. 2005). Under these culture conditions,
the effects of extracellular matrices (ECM) on mESCs were
studied, and the results revealed that laminin promoted
differentiation into epiblast-like cells (Hayashi et al. 2007).
In this study, we assessed the effect of BMP4 on mESC in
the defined culture conditions with fewer extrinsic stim-
ulators. Our results show that mESCs can be induced to
differentiate into trophoblast by BMP4 in vitro. This
differentiation was inhibited by serum or LIF. Furthermore,
we also found that BMP4 activates the Smad pathway in
mESCs, and in turn, the BMP–Smad pathway directly
induces Cdx2 expression, which plays a crucial role in
trophoblast differentiation.
Materials and Methods
Cell culture. The mESC D3 line (CRL-1934, ATCC,
Manassas, VA), B6G-2 line (AES0003, RIKEN Cell Bank,
Ibaraki, Japan), E14 line, or EB3 line was routinely
cultured in 75-cm
2 plastic flasks (Corning, Corning, NY),
coated with 15 µg/ml of type I collagen (Nitta gelatin) in a
humidified atmosphere of 5% CO2 at 37°C in a defined
ESF7 medium. The ESF7 consisted of ESF basal medium
(Cell Science & Technology Institute, Sendai, Japan)
supplemented with 10 µg/ml of insulin, 5 µg/ml transferrin,
10 µM 2-mercaptoethanol, 10 µM 2-ethanolamine, 20 nM
sodium selenite, 9.4 µg/ml of oleic acid conjugated with
2 mg/ml of fatty-acid-free bovine serum albumin (FAF-
BSA; Sigma, St. Louis, MO), and 10 ng/ml of LIF
(Chemicon, Billerica, MA), as described previously (Furue
et al. 2005; Hayashi et al. 2007). For the differentiation
experiments, mESCs were seeded at a density of 1×10
4
cells per square centimeter in the ESF5 medium comprised
of ESF basal medium supplemented with 10 µg/ml of
insulin, 5 µg/ml transferrin, 10 µM 2-mercaptoethanol,
10 µM 2-ethanolamine, 20 nM sodium selenite added with
0.5 mg/ml FAF-BSA, and 10 ng/ml rhBMP4 (R&D
Systems, Minneapolis, MN) on 2 µg/cm
2 laminin-coated
(Sigma) dishes. The medium was changed every 2 d. After
4 d of culture under differentiating conditions, the cells
reached confluency. Then, in all experiments where cells
were differentiated for more than 4 d, the cells cultured for
4 d in BMP4-supplemented ESF5 medium were harvested
with 0.2 mg/ml ethylenediaminetetraacetic acid (EDTA)-
4Na (Sigma) for 5 min at room temperature and subcultured
into BMP4-supplemented ESF5 medium at a density of
about 2×10
4 cells per square centimeter. For the examina-
tion of the effects of activin and FGF4 on the differentiation
of mESCs into trophoblast, the mESCs were cultured in
ESF5 medium supplemented with 25 ng/ml of FGF4
(Sigma) or 10 ng/ml of activin A (Ajinomoto, Kawasaki,
Japan), respectively. When examining the effect of fetal calf
serum (FCS), LIF, and Noggin on the differentiation of
mESCs into trophoblast, the mESCs were cultured in ESF5
medium supplemented with 10 ng/ml of LIF (Chemicon),
10% FCS (ES qualified; Gibco, Grand Island, NY), or
300 ng/ml Noggin (R&D Systems), respectively, along with
BMP4.
Flow cytometry. Flow cytometry was performed with EPICS
ALTRA system (Beckman Coulter) as described previously
(Furue et al. 2005; Hayashi et al. 2007). In this study, goat
anti-Cdh3 antibody (R&D systems) was visualized with
AlexaFluor-488-conjugated mouse antigoat IgG (Invitrogen,
Carlsbad, CA). For DNA content analysis, ethanol-fixed
samples were stained with propidium iodide (PI).
Immunocytochemistry. Immunocytochemistry was per-
formed as described previously (Furue et al. 2005; Hayashi
et al. 2007). Briefly, mESCs were fixed in 4% (w/v)
paraformaldehyde or ice-cold acetone, permeabilized with
0.1% Triton X-100, and reacted with primary antibodies.
The primary antibodies were visualized with AlexaFluor-
488-conjugated antirabbit, antimouse, or antigoat IgG or
AlexaFluor-594-conjugated donkey antimouse, antirabbit,
or antigoat IgG (Invitrogen). The primary antibodies used
are as follows: anti-Cdx2 antibody (Biogenex, San Ramon,
CA; 1:100), anti-Cdh3 antibody (R&D systems; 1:200),
anti-CK7 antibody (Chemicon; 1:100), anti-Cx31 antibody
(Chemicon; 1:100), anti-Nanog antibody (ReproCell,
Tokyo, Japan; 1:200), and anti-SSEA1 antibody (Kyowa,
Tokyo, Japan; 1:100).
Transfection. mESCs wereseededata density of5×10
5 cells
per well in a six-well plate coated with type I collagen in
ESF7. The mESCs were transfected with plasmid DNA
BMP4–SMAD–CDX2 INDUCE TROPHOBLAST FROM MESCS 417using Lipofectamine 2000 (Invitrogen), according to the
supplier’s instructions. For inhibitory Smad overexpression
experiment, Smad6 expression vector comprising whole
Smad6 cDNA under CAG promoter in pCAG-IRES-PURO
plasmid (a gift of Dr. Imamura) was used. The pCAG-IRES-
PURO-FLAG was used as a mock. Transfected cells were
reseeded in ESF5 with 10 ng/ml of BMP4 and 1 µg/ml of
Puromycin, 24 h after transfection. These cells were used for
immunocytochemistry and reverse transcription–polymerase
chain reaction (RT–PCR), 96 h after transfection. For Cdx2-
knockdown experiment, the shRNA for Cdx2 expression
vector consisted of 29-mer shRNA constructs against Mouse
Cdx2 under U6 promoter in pRS plasmid (purchased from
OriGene, Rockville, MD). The pRS plasmid was used as a
mock. Transfected cells were reseeded in ESF7 with 0.5 µg/
ml of Puromycin, 24 h after transfection. After two passages
on this culture conditions, these cells were used for
immunofluorescence detection and RT–PCR.
Chromatin immunoprecipitation assay. For chromatin im-
munoprecipitation (ChIP) assay of endogenous proteins, the
mESCs (D3 line) were cultured in ESF5 medium for 48 h on
lamininandtreatedwith100ng/mlofBMP4for 1h.Thecells
were cross-linked with 1% formaldehyde for 10 min at 37°C.
Tostopthe cross-linking,the sampleswerewashedtwicewith
ice-cold phosphate-buffered saline (PBS) with complete
protease inhibitors mixture (Roche). After gentle washing
with ChIP lysis buffer [1% sodium dodecyl sulfate (SDS),
10 mM EDTA, 50 mM Tris–HCl (pH 8.0), complete protease
inhibitormixture],thesampleswerelysedwith200µlofChIP
lysis buffer. The lysates were then mixed with 800 µl of ChIP
dilution buffer [0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA,16.7mMTris–HCl(pH8.0),167mMNaCl,complete
protease inhibitor mixture] and sonicated four times for 10 s
each at the maximum setting (Sonifier 150; Branson,
Danbury, CT). Then, 1 ml of ChIP dilution buffer was added,
and the samples were centrifuged at 17,000×g for 10 min.
The supernatants were transferred to a fresh centrifuge tube.
An aliquot of 200 µl of the supernatant was stored at 4°C as
the input DNA sample. These supernatants were conjugated
with anti-phospho Smad1/5/8 antibody (Chemicon) or goat
normal IgG (Upstate Biotechnology) bound with Dynabeads
Protein G (Invitrogen) through overnight incubation at 4°C
with rotation. These antibodies were found to adhere to the
Dynabeads Protein G when 5 µg of the antibodies was
incubated in 0.1 mg/ml of BSA in PBS for 1 h at room
temperature with rotation. The beads were collected with
Dynal MPC-S (Invitrogen) and were washed sequentially for
5 min each in low-salt buffer [0.1% SDS, 1% Triton X-100,
2 mM EDTA, 20 mM Tris–HCl (pH 8.0), 150 mM NaCl],
high-salt buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20 mM Tris–HCl (pH 8.0), 500 mM NaCl], and LiCl buffer
[0.25 M LiCl, 1% Nonidet P-40, 1% deoxycholic acid,
1 mM EDTA, 10 mM Tris–HCl (pH 8.0)]. The precipitates
were then washed twice with ChIP TE buffer [10 mM Tris–
HCl (pH 8.0), 1 mM EDTA] for 5 min. The immunocomplex
was extracted twice by incubation for 30 min at room
temperature with 200 µl of ChIP elution buffer (1% SDS,
0.1 M NaHCO3, 10 mM DTT). The eluates and input DNA
solutions were supplemented with 5 M NaCl to a final
concentration of 200 mM and heated at 65°C for 8–12 h to
reverse the formaldehyde cross-linking. All the samples were
sequentially treated for 30 min with RNase I (Wako) at 37°C
and for 1 h with proteinase K (Takara Bio) at 55°C. The
DNA fragments were purified using the QIAquick PCR
purification Kit (Qiagen, Hilden, Germany) and analyzed by
PCR. The primers, annealing temperature, and number of
cycles in the PCR analysis are as follows: for Cdx2 Intronic
Conserved Sequence 1 (CICS1), forward, 5′-GGGCCA
CAGCTTCCCTACAT-3′ and reverse, 5′-TGGGTGGTCCGA
GACTAGGG-3′, 60°C, 31 cycles; for DS 4 kb, forward, 5′-
ATGCCAGAGCCAACCTGGAC-3′ and reverse, 5′-
CTCCCGACTTCCCTTCACCA-3′, 60°C, 32 cycles; and for
US 4 kb, forward, 5′-AGCCAAG GACCCTTGTTGCT-3′ and
reverse, 5′–GGGGACTTGAA CACCCTTCC-3′, 60°C, 32
cycles.
Electrophoretic mobility shift assay. The proteins used in
the electrophoretic mobility shift assay (EMSA) were
transcribed and translated from the expression vectors
pCS2-GST-Smad1 and pCS2-GST-Smad4 in BL21 E. coli
strain. The probes generated from the sense and the
antisense oligonucleotides were labeled with Cy5.5
(Sigma-Aldrich), mixed, and annealed. The DNA–protein
binding reaction was performed in the binding buffer
[20 mM HEPES (pH 7.8), 45 mM KCl, 10 mM NaCl,
1 mM EDTA, 10% (vol/vol) glycerol, 0.1% Nonidet P-40,
0.2 mg/ml BSA, 1 mM DTT] at 4°C for 1 h. After
electrophoresis, the binding reactions were analyzed by
using the Odyssey image reader (Li-Cor, Lincoln, NE;
ALOKA, Tokyo, Japan) for the Cy5.5-labeled probe. The
sense strand sequences of the probes used in EMSA are as
follows: 5′-ACAAGGGCGCCCGGCGCCGACAGCGG
TCTTGCCACCTCGGCGCGGGACTT-3 ′.
Luciferase assay. The pGL4.74 (Promega) plasmid was
used as an internal control. Cultured cells were transfected
with the reporter vectors (pGL4.23 with Cdx2-intron1
firefly, 4 µg; Renilla, 100 ng) and were harvested 48 h
after transfection. Reporter activities were measured by
using the dual-luciferase reporter assay system (Promega).
Each assay was performed in duplicate, and all the results
presented the mean values (n=4).
RT–PCR. RT–PCR was performed as described previously
(Furue et al. 2005; Hayashi et al. 2007). Briefly, total RNA
418 HAYASHI ET AL.was extracted from the cultured cells using the total RNA
extraction kit (Agilent, Wilmington, DE) and reverse-
transcribed using Quantitect RT kit (Qiagen). Quantitative
real-time PCR was performed with SYBR Green PCR
Master Mix according to the supplier’s directions (Applied
Biosystems, Foster City, CA) in ABI PRISM 7700
sequence detector or Step One Plus sequence detector
(Applied Biosystems). Relative expression of mRNA was
calculated and compared with the expression in mouse
whole-day 10.5 embryos or 12.5 placenta. Conventional
PCR for the detection of trophoblast marker expression or
ChIP assay was performed with SYBR Green PCR Master
Mix according to the supplier’s directions. The sequences
of the primers are listed in the Table 1. All the results are
given as the mean values (n=4).
Western blot. Western blot was performed as described
previously (Furue et al. 2005; Hayashi et al. 2007). Briefly,
to detect the phosphorylation of Smads, mESCs were seeded
at a density of 6×10
5 cells per square centimeter on six-well
plates in the ESF basal medium and were stimulated using
100 ng/ml of BMP4 for 0, 15, or 60 min. The cells were
lysed in 200 µl of ice-cold lysis buffer (50 mM Tris–HCl
(pH 7.4), 150 mM NaCl, 0.1% SDS, 1 mM Na3Vo4,0 . 5 %
sodium deoxycholate, 5 mM EDTA, 1% NP-40) and 250 µl
of PBS. Protein samples (25 or 50 µg) were separated in a
12.5% SDS–polyacrylamide gel and electroblotted to a
polyvinylidene fluoride membrane (Amersham, Piscataway,
NJ). After incubating in the blocking buffer for 30 min at
room temperature, the membrane was incubated with
primary antibodies overnight at 4°C. The primary antibodies
used are as follows: anti-α-tubulin (Sigma, 1:1,000), anti-
Smad1/5/8 (Santa Cruz Biotechnology, Santa Cruz, CA,
1:1,000), anti-phospho Smad1/5/8 (Cell Signaling Technol-
ogy, Beverly, MA, 1:1,000), and anti-Smad6 (Abcam,
Cambridge, UK, 1:1,000). The membranes were then reacted
with secondary antibodies followed by horseradish peroxi-
dase substrate, according to the supplier’sp r o t o c o l( P i e r c e
Biotechnology, Rockford, IL). Protein bands on the mem-
branes were visualized with LAS-1000 and PRO-LAS 1000
software (Fujifilm, Tokyo, Japan).
Results
The characterization of BMP4-treated cells in defined
conditions. We observed morphological changes of the
cells when undifferentiated mES cells at a density of 5×
10
3 cells per square centimeter were cultured in ESF5
medium supplemented with 10 ng/ml BMP4 on laminin-
coated dishes for 4 d. The morphology of the majority of
cells became cobblestone-shaped (Fig. 1A, left). Before the
cells reached to confluent, we subcultured the cells into the
same culture conditions at a density of 2×10
4 cells per
square centimeter on culture day 4. After four additional
days in culture, multinuclear cells appeared (Fig. 1A, right).
Trophoblast stem cells (TSCs) exhibit a cobblestone
morphology (Tanaka et al. 1998) and subsequently differ-
entiate into multinuclear trophoblast (Simmons and Cross
2005). These findings suggested the possibility that mESCs
cultured with BMP4 in ESF5 might differentiate into
trophoblast lineages. To explore this possibility further,
we examined the gene expression of transcription factors
which are expressed in trophoblast, Cdx2 (Strumpf et al.
2005), Dlx3 (Morasso et al. 1999), Eomes (Russ et al.
2000), Errb (Luo et al. 1997), Esx1 (Li and Behringer
1998), Ets2 (Yamamoto et al. 1998), Gata3 (Ng et al.
1994), Hand1 (Cross et al. 1995), Mash2 (Guillemot et al.
1995), and Psx1 (Chun et al. 1999) in the differentiated
cells by quantitative real-time RT–PCR. The relative
mRNA levels of the majority of these transcription factors
were increased over tenfold compared with those of the
undifferentiated mESCs (Fig. 1B). The mRNA levels of
Eomes, Errb,a n dEts2, which were involved in self-
renewal of undifferentiated TSCs (Luo et al. 1997; Russ
et al. 2000; Wen et al. 2007), were not increased. To
confirm whether BMP4 specifically activates the expression
of trophoblast markers, we examined the transcription of
other cell lineage markers in early mammalian develop-
ment, Sox1 (ectoderm), Flk1 (mesoderm), Mixl1 (definitive
endoderm), and Gata6 (primitive extraembryonic endo-
derm) in the cells cultured with BMP4 in ESF5 medium on
culture day 4 by quantitative real-time RT–PCR. The gene
expression of the ectoderm, mesoderm, definitive endo-
derm, or extraembryonic endoderm cell lineage markers
examined here was no higher than that in undifferentiated
mESCs (Fig. 1C). These results indicate that the differen-
tiated cells specifically upregulated transcription factors for
trophoblast.
As the mESCs proliferated in a dose-dependent manner
in response to BMP4 concentration in ESF5 medium
(Fig. 1D) and did not proliferate without addition of
BMP4, we could not compare the gene expression with
those in the BMP4-untreated cells. To examine whether
these genes were specifically induced in BMP4-treated cells
or not, we compared the effect of FGF4 or activin with that
of BMP4 on mESC gene expression. Gene expression
profiles in the cells cultured with BMP4, activin, or FGF4
in ESF5 on laminin for 4 d were analyzed by quantitative
RT–PCR. FGF-4 increased the Cdx2 expression in the cells
as BMP4 did, but activin did not increase Cdx2 expression.
NeitherFGF-4noractivinincreasedtheexpressionofDlx3,
Esx1, Gata3, Hand1, Mash2,o rPsx1 (Fig. 1E). These
results indicated that BMP4 specifically upregulated the
expression of these trophoblast-specific transcription
factors.
BMP4–SMAD–CDX2 INDUCE TROPHOBLAST FROM MESCS 419To characterize these putative trophoblast cells, we
further analyzed the expression of the trophoblast marker
proteins Cdh3 (placental cadherin; Nose and Takeichi
1986), Cdx2, cytokeratin (CK) 7 (Lu et al. 2005), and
connexin (Cx) 31 (Zheng-Fischhofer et al. 2007), by
immunocytochemistry. The differentiated cells expressed
Cdh3, Cdx2, CK7, and Cx31 proteins (Fig. 2A). Further-
more, we examined the expression of additional
trophoblast-specific genes: Gcm1 (Anson-Cartwright et al.
2000), Placental lactogen (Pl)-1 (Faria et al. 1991), Plf
(Simmons et al. 2008), Tpbpa, and Tpbpb (Lescisin et al.
1988)b yR T –PCR. These trophoblast markers are
expressed at much higher levels in placenta than in whole
embryos. The expression of trophoblast marker genes was
prominent in the cells cultured with BMP4 in ESF5 for 8 d
(Fig. 2B). By flow cytometry analysis, 83.2% of cells
cultured with BMP4 in ESF5 were positive for Cdh3
expression (Fig. 2C). These results indicate that the
majority of the differentiated cells exhibit trophoblast
characteristics. We observed multinuclear cells surrounded
by Cdh3 in this culture conditions, which is a characteristic
of differentiated trophoblast (Simmons and Cross 2005;
Fig. 2D). To examine the frequencies of multinuclear cells
in the culture, the intensity of PI in the cells cultured with
BMP4 in ESF5 for 8 d was examined. A small population
of hyperploid cells (>4 N) was observed in the differenti-
ated cell cultures (Fig. 2E). The percentage of hyperploid
cells (>4 N) was 37% in the cells, suggesting the presence
of multinuclear differentiated trophoblast. We have con-
firmed that other mESC lines, B6G-2, E14, and EB3, also
Names Sequences Product size Cycles
Cdx2 5′-CTGCTGTAGGCGGAATGTATGTCT-3′ 146 –
5′-AAGGCTTGTTTGGCTCGTTACAC-3′
Dlx3 5′-TACTCGCCCAAGTCGGAATA-3′ 174 –
5′-AGTAGATCGTTCGCGGCTTT-3′
Eomes 5′-CGGCAAAGCGGACAATAACA-3′ 195 –
5′-ATGTGCAGCCTCGGTTGGTA-3′
Errb 5′-GCTGTATGCTATGCCTCCCAACG-3′ 166 –
5′-ACTCTGCAGCAGGCTCATCTGGT-3′
Esx1 5′-GAGCTGGAGGCCTTTTTCCA-3′ 194 –
5′-ACACCCACAGGGGGACTCAT-3′
Ets2 5′-CTCGGCTCAACACCGTCAAT-3′ 132 –
5′-AGCTGTCCCCACCGTTCTCT-3′
Flk1 5′-TCCTACAGACCCGGCCAAAC-3′ 163 –
5′-ACACGTTGGCAGCTTGGATG-3′
Gapdh 5′-ACCCAGAAGACTGTGGATGG-3′ 173 –
5′-CACATTGGGGGTAGGAACAC-3′
Gata3 5′-GGGCTACGGTGCAGAGGTAT-3′ 163 –
5′-TGGATGGACGTCTTGGAGAA-3′
Gcm1 5′-TACCTGAGACCCGCCATCTG-3′ 152 35
5′-AAGATGAAGCGTCCGTCGTG-3′
Hand1 5′-TCGCCGAGCTAAATGGAGAA-3′ 124 –
5′-TGCTGAGGCAACTCCCTTTT-3′
Mash2 5′-CGGGATCTGCACTCGAGGAT-3′ 183 –
5′-GGTGGGAAGTGGACGTTTGC-3′
Mixl1 5′-AAGTTGGGGAGTACACAATG-3′ 195 –
5′-CACCATACCACACATATGGA-3′
Pl1 5′-CATTTGGCTGAACTGTCTCA-3′ 111 35
5′-GACTTCCTCTCGATTCTCTG-3′
Plf 5′-AGGAACAAGCCAGGCTCACA-3′ 178 35
5′-TTCCGGACTGCGTTGATCTT-3′
Psx1 5′-CGATGGATGGGTGTGGATGA-3′ 165 –
5′-TGACAGGGCTGGCACTCAAG-3′
Sox1 5′-GTCATGTCCGAGGCCGAGAA-3′ 118 –
5′-AGCAGCGTCTTGGTCTTGCG-3′
Tpbpa 5′-AGTCCCTGAAGCGCAGTTGG-3′ 138 35
5′-TTGGAGCCTTCCGTCTCCTG-3′
Tpbpb 5′-GTCATCCTGTGCCTGGGTGT-3′ 163 35
5′-TGCCATCCTTCTCCTGGTCA-3′
Table 1. Primer pairs used in
RT–PCR
420 HAYASHI ET AL.Figure 1. The effect of BMP4 on mESCs in defined culture
conditions. (A) phase contrast photomicrographs of differentiated
mESCs cultured in BMP4-supplemented ESF5 medium for 4 d (left)
and 8 d (right). Scale bars are 100 µm. (B) quantitative real-time RT–
PCR analysis of trophoblast-specific transcription factor expressions.
The mESCs cultured in BMP4-supplemented ESF5 medium for 0, 2,
4, 6, and 8 d were analyzed. (C) Quantitative RT–PCR analysis of
differentiation markers of mESCs. The cells cultured in BMP4-
supplemented ESF5 medium for 4 d were analyzed. The amount of
undifferentiated mESCs is indicated as 1. (D) Proliferation of
differentiating mESCs on various BMP4 concentrations. mESCs were
seeded in a 24-well dish at 5×10
3 cells per well on each BMP4
concentration in ESF5. Cells were counted every 24 h. The values are
the mean ± SEM (n=4). (E) quantitative RT–PCR analysis of BMP4-
induced trophoblast transcription factors in mESCs cultured in BMP4,
activin A (10 ng/ml), or FGF4-supplemented (25 ng/ml) ESF5
medium on laminin for 4 d was analyzed. The gene expressions were
normalized by the amount of Gapdh. The amount of the undifferen-
tiated mES is indicated as 1. The values are the mean ± SEM (n=4).
BMP4–SMAD–CDX2 INDUCE TROPHOBLAST FROM MESCS 421differentiated into trophoblast-like cells under these con-
ditions (data not shown).
We examined the effect of extracellular matrix on the
differentiation into trophoblast cells from mESCs. We
found that the cells steadily proliferated and expressed
CK7 when mESC were cultured with BMP4 in ESF5 on
fibronectin or laminin (Fig. 3). In contrast, the cells died
and failed to express CK7 on type I collagen or PDL. These
results indicate that fibronectin and laminin promoted
mESC differentiation into trophoblast lineages.
The effect of serum and LIF on mESC differentiation into
trophoblast cells. Although it is generally accepted that few
mESCsdifferentiateintotrophoblastlineages,wesuccessfully
directed differentiation of several mESC lines into trophoblast
cells. We presume that this phenotype stems from our use of
serum-free culture conditions. To elucidate the effects of
serumonmESCdifferentiationintotrophoblast,wecompared
trophoblast marker expression in the cells cultured with
BMP4 in ESF5 medium in the presence or absence of 10%
FCS. The addition of FCS decreased BMP4-induced expres-
sion of trophoblast transcription factors (Fig. 4A)a n dC d h 3
protein expression (Fig. 4B). These results indicate that FCS
inhibited the differentiation of mESCs into trophoblast.
Another candidate inhibitor of mESC differentiation into
trophoblast is LIF, which is known to maintain mESCs in the
undifferentiated state (Smith et al. 1988; Williams et al.
1988). To elucidate the effects of LIF on trophoblast
differentiation, we examined trophoblast gene expression in
cells cultured with BMP4 in the presence or absence of 10 ng/
Figure 2. Differentiation into trophoblast from mESCs in vivo. (A)
Immunocytostaining with trophoblast marker antibodies of the cells
cultured in BMP4-supplemented ESF5 medium for 4 d (right)o r
undifferentiated mESCs (left). Immunoreactivity of Cdh3 (upper left),
Cdx2 (upper right), CK7 (lower left), and Cx31 (lower right) was
visualized with AlexaFluor-488-conjugated secondary antibodies
(green). Nuclei were stained with DAPI (blue). Scale bars were
50 µm. (B)R T –PCR analysis of the expression of placental markers in
differentiated mESCs. (C) Flow cytometric analysis of mESCs (blue)
and differentiated cells at eight culture days (red). (D) Immunocytos-
taining with anti-Cdh3 antibodies of the cells cultured in BMP4-
supplemented ESF5 medium for 8 d. Arrows indicate the nuclei of
hyperploid cells. Scale bars were 50 µm. (E) Flow cytometric analysis
of mESCs (blue) and differentiated cells at eight culture days (red).
The DNA contents were visualized with propidium iodide. Diploid
(2N), tetraploid (4N), and octaploid (8N) DNA contents are indicated
in the DNA content graph.
422 HAYASHI ET AL.ml of LIF in ESF5. Addition of LIF decreased the BMP4-
induced expression of trophoblast-specific transcription factors
(Fig. 4C) and Cdh3 protein expression (Fig. 4D) and
enhanced the expression of undifferentiated pluripotent stem
cell markers, Nanog and SSEA1 (Fig. 4E). These results
suggested that LIF inhibited differentiation of mESCs into
trophoblast and confirmed that BMP4 in conjunction with LIF
functions to maintain the undifferentiated state of mESCs.
Involvement of BMP–Smad pathway in mESC differentiation
into trophoblast. To examine whether BMP4 itself may
promote the differentiation of mESCs into trophoblast, we
Figure 3. The effect of ECM
components on the differentiation
into trophoblast from mESCs.
(A) Proliferation of differentiating
mESCs on various ECM com-
ponents. mESCs were
seeded in a 24-well dish at 5×
10
3 cells per well on each ECM
c o m p o n e n ti nE S F 5m e d i u m
supplemented with BMP4. Cells
were counted every 48 h. The
values are the mean ± SEM
(n=3). (B) Immunocytostaining
and TUNEL assay of the differ-
entiated mESCs cultured for 4 d
in BMP4-supplemented medium.
As trophoblast markers, CK7
was detected with specific
antibodies (red). TUNEL assay
(Chemicon) was performed
according to the manufacturers’
direction and labeled fixed cells
with fluorescence (green). Nuclei
were stained with DAPI (blue).
Scale bars are 50 µm. (C)
Percentages of CK7-positive
cells. Percentages are calculated
from the observation of more
than 500 cells for each sample.
The values are the mean + SEM
(n=3). (D) Percentages of
TUNEL-positive cells. Percen-
tages are calculated from the
observation of more than 500
cells for each sample. The values
are the mean + SEM (n=3).
BMP4–SMAD–CDX2 INDUCE TROPHOBLAST FROM MESCS 423tested the effects of a BMP antagonist, Noggin (300 ng/ml),
on the response of mESCs to BMP4. Addition of Noggin
decreased the BMP4-induced expression of trophoblast
transcription factors (Fig. 5A) as well as Cdh3 (Fig. 5B)
in the differentiated cells. This result indicated that BMP4
itself promoted the mESC differentiation into trophoblast.
Next, we examined whether the BMP–Smad pathway
was involved in the BMP4-induced differentiation of
Figure 4. Effect of FCS and LIF on the differentiation into
trophoblast. The effect of FCS: the cells were cultured in BMP4-
supplemented ESF5 medium with 10% FCS (indicating as “BMP4
with FCS”) or without FCS (indicating as “BMP4 only”) for 4 d. (A)
Quantitative real-time RT–PCR analysis of the expression of
trophoblast-specific transcription factors. The gene expressions were
normalized by the amount of Gapdh. The values are the mean ± SEM
(n=4). (B) Immunocytochemistry with Cdh3 antibodies. Immuno-
positive reaction of Cdh3 antibody was visualized with AlexaFluor-
488-conjugated secondary antibodies (green). Nuclei were stained
with DAPI (blue). Scale bars are 50 µm. The effect of LIF: the cells
were cultured in BMP4-supplemented ESF5 medium with 10 ng/ml of
LIF (indicating as “BMP4 with LIF”) or without LIF (indicating as
“BMP4 only”) for 4 d. (C) Quantitative real-time RT–PCR analysis of
the expression of trophoblast-specific transcription factors. (D)
Immunocytochemistry with Cdh3 antibodies. (E) Immunocytochem-
istry with anti-Nanog or anti-SSEA1 antibodies. Immunopositive
reaction of anti-Nanog or anti-SSEA1 antibody was visualized with
AlexaFluor-488-conjugated secondary antibodies (green).
424 HAYASHI ET AL.mESCs into trophoblast. Western blotting analysis
showed that the activation by phosphorylation of
Smad1/5/8 was observed in cells treated with BMP4
(Fig. 5C). Furthermore, the overexpression of Smad6
(Fig. 5D), which inhibits the transcriptional activity of
Smad proteins, decreased the BMP4-induced expression
of trophoblast transcription factors (Fig. 5E)a sw e l la s
Cdh3 (Fig. 5F) in the differentiated cells. These results
indicated that BMP4-stimulated differentiation of mESCs
into trophoblast is mediated through by the Smad pathway.
IdentificationofCdx2 as a critical and direct target of BMP–
Smad pathway in mESC differentiation into trophoblast.
Next, we searched for a crucial gene involved in tropho-
blast differentiation induced by BMP4. Previous studies
have demonstrated that Cdx2 regulates the induction of
trophoblast from mESCs (Niwa et al. 2005; Tolkunova et
al. 2006). Thus, we hypothesized that Cdx2 could be a
crucial gene involved in trophoblast differentiation by
BMP4. We generated Cdx2-knockdown mESCs carrying
an shRNA plasmid against Cdx2 with a puromycin-
Figure 5. The effects of Noggin, inhibitory Smad6 on the BMP4-
induced differentiation of mESCs into trophoblast. The effect of
Noggin: the cells were cultured in BMP4-supplemented ESF5 medium
with 300 ng/ml of Noggin (indicating as “BMP4 with Noggin”)o r
without Noggin (indicating as “BMP4 only”)f o r4d .( A)
Quantitative real-time RT–PCR analysis of the BMP4-induced
expression of trophoblast-specific transcription factors. These gene
expressions were normalized by the amount of Gapdh. The values are
the mean ± SEM (n=4). (B) Immunocytostaining with Cdh3 anti-
bodies. Immunoreactivity of Cdh3 antibody was visualized with
AlexaFluor-488-conjugated secondary antibodies (green). Nuclei were
stained with DAPI (blue). Scale bars were 50 µm. The effect of
inhibitory Smad; (C) protein samples were lysed from the mESCs
stimulated by 100 ng/ml of B M P 4f o r0 ,1 5 ,a n d6 0m i n .
Phosphorylation level of Smad1/5/8 in mESCs was analyzed by
Western blotting using antibodies to phospho Smad1/5/8 proteins or
total Smad1/5/8 proteins. Alpha-tubulin was used as the loading
control. (D) Protein samples were lysed from mESCs transfected with
Smad6 plasmids (indicating as “Smad6 OE”) or mock plasmids
(indicating as “Mock”) for 48 h. Protein content of Smad6 in mESCs
was analyzed by Western blotting using antibodies to Smad6 proteins.
Alpha-tubulin was used as the loading control. (E)T h ec e l l s
transfected with Smad6-expressing vectors (indicating as “Smad6
OE”) or mock vectors (indicating as “Mock”) were cultured in BMP4-
supplemented ESF5 medium for 72 h. Quantitative real-time RT–PCR
analysis of the BMP4-induced expression of trophoblast-specific
transcription factors. (F) Immunocytostaining with Cdh3 antibodies.
BMP4–SMAD–CDX2 INDUCE TROPHOBLAST FROM MESCS 425resistance gene. The expression of Esx1 and Psx1 (Fig. 6A)
and the expression of Cdh3 protein were decreased in the
Cdx2-knockdown mESCs cultured with BMP4 in ESF5
(Fig. 6B). These results suggested that Cdx2 was crucial
for the BMP4-induced differentiation of mESCs into
trophoblast through the regulation of the expression of
Esx1 and Psx1.
Finally, we explored the possibility that BMP–Smad
pathway could directly regulate the Cdx2 transcription. We
first searched for the putative Smad1/5/8-binding sequence
(GCCG) in the noncoding conserved sequences in the
genomic region of Cdx2 using the Vista comparative
genomics tool (Frazer et al. 2004; Danno et al. 2008). We
found a set of putative Smad1-binding sequences (GCCG)
highly conserved among mammals in intron 1 of the Cdx2
gene, designated as CICS1 (Fig. 7A). We cloned a 350-bp
sequence containing CICS1 and inserted it into the
pGL4.23 luciferase reporter plasmid. To confirm that this
sequence has enhancer activity in response to BMP4, a
luciferase reporter assay was performed in mESCs trans-
fected with the reporter plasmid or empty plasmid.
Transcriptional activity was increased in a BMP4 dose-
dependent manner in transfected mESCs, whereas Noggin
(300 ng/ml) decreased BMP4-induced transcriptional activ-
ity (Fig. 7B). These results indicate that CICS1 has BMP4-
dependent transcriptional activity. To examine whether
Smad proteins can bind to CICS1, we performed EMSA.
EMSA revealed that the Smad proteins were bound to
CICS1 in vitro (Fig. 7C). To confirm whether endogenous
Smad proteins were bound to CICS1 in the BMP4-induced
trophoblast cells, we performed ChIP assays (Fig. 7D, E).
The CICS1 sequence was specifically contained in the
DNA–protein complex immunoprecipitated by the anti-
pSmad1 antibodies. These results demonstrate specific
binding of the Smad1 proteins to CICS1 in BMP4-treated
mESCs. Based on the experimental results obtained here,
we conclude that Cdx2 transcription is directly regulated by
the BMP–Smad pathway during BMP4-induced mESC
differentiation.
Discussion
Previous studies reported that isolated ICM could partially
differentiate into trophoblast (Handyside 1978; Hogan and
Tilly 1978) whereas it was reported that mESCs did not
contribute to extraembryonic trophoblast in chimeric
embryos (Beddington and Robertson 1989). From these
findings, we inferred that mESCs under certain conditions
have the potential to differentiate into trophoblast lineages
as well as all three embryonic germ layers. Toumadje et al.
observed spontaneous expression of the trophoblast marker
cytokeratin endo-A (CK8) in D3 mESC embryoid bodies
cultured in serum in the absence of LIF (Toumadje et al.
2003). A recent study reported that a small subset of
trophoblast-like cells appeared when mESCs were cultured
on type IV collagen (Schenke-Layland et al. 2007). Another
study reported that the addition of Wnt3a induced a small
subset of trophoblast lineages from mESCs (He et al.
2008). These findings suggested that mESCs may have the
potential to differentiate into trophoblast lineages and that
the modulation of culture conditions regulates mESCs to
differentiate into trophoblast in vitro.
To induce trophoblast from mESCs, laminin proved to
be a key component. We previously reported that laminin or
fibronectin promotes cell differentiation in our defined
culture conditions (Hayashi et al. 2007). The results in this
study indicated that mESC differentiated into trophoblast
Figure 6. The effects of shRNA against Cdx2 on the BMP4-induced
differentiation of mESCs into trophoblast. The cells carrying shRNA-
expressing vectors against Cdx2 (indicating as “Cdx2 shRNA”)o r
control shRNA-expressing vectors (indicating as “Control shRNA”)
were cultured in BMP4-supplemented ESF5 medium for 48 h. (A)
Quantitative real-time RT–PCR analysis of the BMP4-induced
expression of trophoblast-specific transcription factors. These gene
expressions were normalized by the amount of Gapdh. The values are
the mean ± SEM (n=4). Asterisks indicate p<0.05 by Student’s t test.
(B) Immunocytostaining with Cdh3 antibodies. Immunoreactivity of
Cdh3 antibody was visualized with AlexaFluor-488-conjugated
secondary antibodies (green). Nuclei were stained with DAPI (blue).
Scale bars were 50 µm.
426 HAYASHI ET AL.lineages only on fibronectin or laminin. Thus, our findings
suggested that laminin regulates mESCs differentiation into
trophoblast in the defined culture condition. Previous
studies using serum or serum replacement which contain a
variety of ECM components most likely associated with an
ill-defined cocktail of growth factors. We have suggested
that serum hampers the elucidation of the biological
mechanisms and gives rise to apparently different con-
clusions on the ability of ESCs to differentiate into
trophoblast.
HESCs have been reported to express trophoblast
markers after treatment with BMP4 in vitro (Xu et al.
2002). Previous studies reported that mouse epiblast stem
cells or a subpopulation of epiblast-like mESCs express
trophoblast markers in response to BMP4 (Brons et al.
2007; Hayashi et al. 2008). Mouse epiblast stem cells
resemble hESCs more closely than mESCs (Brons et al.
2007; Tesar et al. 2007; Hayashi et al. 2008). We have
previously found polarized cell morphology and the
upregulation of Fgf5 expression and downregulation of
some self-renewal marker gene expression in mESCs
cultured on laminin or fibronectin (Hayashi et al. 2007).
These are characteristics of epiblast cells. In this study, cells
were treated with BMP4 on laminin in our defined culture
conditions. Our findings suggest that the differentiation via
an epiblast-like state is important for mESC differentiation
into trophoblast, and BMP4 can induce from both human
and mouse pluripotent stem cells to differentiate into
trophoblast.
As described above, BMP4 is a key component
promoting trophoblast differentiation from both mESCs
and hESCs (Xu et al. 2002). These findings contradict
previous reports in which BMP4 supported cell self-
renewal. However, that was observed with BMP4 in
conjunction with LIF (Ying et al. 2003; Qi et al. 2004).
BMP4 supports mESC self-renewal by inhibiting neural
differentiation which is not inhibited by LIF. We have
shown in this study that LIF inhibits trophoblast differen-
tiation by BMP4. These results suggest that LIF and BMP4
reciprocally inhibit differentiation of mESCs into neural or
trophoblast lineages and lead to maintain self-renewal of
mESCs. Previous studies have also reported that BMP4 is
also thought to be involved in mesoderm differentiation
from ESCs (Johansson and Wiles 1995; Wiles and
Johansson 1999; Nostro et al. 2008; Sumi et al. 2008).
These studies employed other signal activation by cyto-
kines or tight cell–cell attachments. Our results suggest that
BMP4 induces differentiation into trophoblast in defined
conditions in the absence of other activating signals and
that differentiation was perturbed by the addition of serum.
Thus, BMP4 may function as trophoblast inducer when it
acts alone and as mesoderm inducer when it is coordinated
with other as yet unidentified signals.
We demonstrate thatthe BMP4–Smadpathway is involved
in mESC differentiation into trophoblast. Components of
BMP–Smad pathway are expressed in extraembryonic tissues
and affect their development (Lechleider et al. 2001;
Tremblay et al. 2001). Previous study reported that Nanog
protein, which maintains mESC self-renewal, binds to
Smad1 protein and inhibits the transcriptional activity of
Smad1 protein in mESCs (Suzuki et al. 2006). Our results
reveal that the expression of Nanog protein was absent from
cells cultured with BMP4 in ESF5 but expressed in cells in
the presence of LIF. Thus, Nanog expression induced by LIF
might inhibit mESC differentiation into trophoblast.
Our knockdown experiment showed that the cells which
have reduced Cdx2 expression did not express Esx1, Psx1,
and Cdh3. Cdx2 is essential for trophoblast lineages
development in vivo (Niwa et al. 2005; Strumpf et al.
2005). Thus, our data imply that these cells may differen-
tiate into cell lineages other than trophoblast. Although the
characterization of these cell lineages is interesting for
further experiment, they may be induced by BMP4 and not
express Cdx2.
We also demonstrate that BMP–Smad pathway activates
the Cdx2 expression during the differentiation of mESCs
into trophoblast and that the Cdx2 expression is directly
regulated by the BMP–Smad pathway through binding
of Smad1 protein with evolutionary conserved intronic
enhancer in Cdx2 gene. Correlation between BMP–Smad
pathway and CDX2 expression is reported in human gastric
cancer cell lines (Barros et al. 2008). Together with the fact
that BMP4 increases the trophoblast marker gene expres-
sion in hESCs (Xu et al. 2002), we conclude that common
developmental and molecular mechanisms are involved in
the differentiation of mammalian pluripotent stem cells into
trophoblast. We believe that our methods and findings in
this study provide a better understanding of the molecular
mechanisms that regulate the differentiation of pluripotent
Figure 7. Direct activation of Cdx2 by BMP–Smad pathway. (A)
Conserved sequence domain in the genomic region of Cdx2 gene in
vertebrates. Colored peaks (purple, coding; pink, non-coding) indicate
the regions of at least 100 bp and 60% homology. Magnified sequence
of CICS1 compared between human and mouse is shown in the
bottom part. Putative Smad1 protein binding sequences (GCCG or
CGGC) are enclosed in green box.( B) Dual-luciferase assay of CICS1
transcriptional activity by BMP4. The cells carrying the reporter
vectors constructed with the sequence containing CICS1 were cultured
in BMP4-supplemented ESF5 medium for 48 h. N.C. indicates empty
vectors. The values are the mean ± SEM (n=4). (C) EMSA of CICS1
bound by Smad1 and the cofactor, Smad4. (D) ChIP assays of CICS1
bound by pSmad1. Genomic fragments of CICS1, 4 kb upstream or
4 kb downstream regions bound by pSmad1/5/8 protein, were
immunoprecipitated with anti-pSmad1/5/8 antibody and were ana-
lyzed by PCR. (E) Quantitative graphs of ChIP assays calculated from
the ratio of the amount of bound anti-pSmad1 antibodies to the
amount of control IgG. The values are the mean ± SEM (n=4). *
indicates p<0.05 by Student’s t test.
b
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mammalian development.
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